AliveCor QT Service vs Zio AT ECG Monitoring System

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 68/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by AliveCor
VS
by iRhythm Technologies, Inc.

AI Verdict

Tool A specializes in instant and accurate QT/QTc interval measurements from 6-lead ECGs, primarily for cardiac safety and medication prescribing decisions. In contrast, Tool B offers continuous, long-term ECG monitoring via a wearable patch for comprehensive arrhythmia detection over an extended period. While both utilize AI for cardiac analysis, their distinct focus on specific measurements versus prolonged monitoring makes them suitable for different clinical applications within cardiology.

Choose AliveCor QT Service if…

Choose AliveCor QT Service if you require instant and accurate QT/QTc interval measurements from a 6-Lead ECG to assess immediate cardiac safety. This tool is ideal for healthcare professionals needing to quickly inform medication prescribing decisions or adjust existing drug regimens based on potential QT prolongation risks.

View AliveCor QT Service →

Choose Zio AT ECG Monitoring System if…

Choose Zio AT ECG Monitoring System if your primary goal is continuous, long-term arrhythmia detection over several days, including both symptomatic and asymptomatic events. This system is best suited for patients where paroxysmal or infrequent arrhythmias are suspected, requiring extended, uninterrupted ECG recording to capture elusive cardiac events.

View Zio AT ECG Monitoring System →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature AliveCor QT Service Zio AT ECG Monitoring System
Pricing Varies by product and service, with subscription options available. Contact for pricing
Deployment Mobile app, cloud-based platform, EHR integration. Cloud-based (data analytics and clinician portal)
BAA Available Yes AI-estimated Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

AliveCor QT Service

AliveCor QT Service integrates with existing KardiaMobile 6L devices, offering instant QT measurements through a cloud-based SaMD and existing KardiaStation/KardiaPro portals. This approach leverages familiar workflows for healthcare professionals already using AliveCor products, potentially offering a more streamlined and immediate assessment experience.

Clinical Value

Zio AT ECG Monitoring System

The Zio AT ECG Monitoring System provides continuous, long-term (up to 14 days) AI-powered ECG monitoring for comprehensive arrhythmia detection, including both symptomatic and asymptomatic events. This extended, uninterrupted data collection offers a more complete clinical picture for diagnosing intermittent cardiac conditions compared to Tool A's focused, instant QT interval measurements.

Pricing & Value

Tie

Both tools explicitly state that pricing details are not publicly disclosed and require contacting the vendor. Without transparent pricing information for either product, it is impossible to conduct a meaningful head-to-head comparison of their cost-effectiveness or overall value proposition.

Enterprise Readiness

AliveCor QT Service

AliveCor QT Service explicitly highlights the availability of an API for integration with a broad range of enterprise platforms, including EHR, SDK, CRM, EDC, and PSP. This robust integration capability demonstrates a higher level of readiness for seamless adoption and scalability within complex healthcare IT ecosystems compared to Tool B, which does not detail similar API offerings in its specifications.

Innovation

Zio AT ECG Monitoring System

The Zio AT ECG Monitoring System showcases greater innovation through its integrated wearable patch for continuous, long-term ECG recording with real-time data transmission via a wireless gateway. This comprehensive, end-to-end remote monitoring solution, combining a patient-friendly wearable with advanced AI for extended diagnostics, represents a more significant advancement in cardiac care delivery.

Support & Docs

Zio AT ECG Monitoring System

iRhythm provides extensive 'Instructions for Use' for its Zio AT system, covering device application, wear, and return, alongside dedicated clinician and patient portals with supporting documentation. While AliveCor offers a resource hub and user guides, Zio AT's readily available and detailed instructional materials for both users and patients suggest a slightly more comprehensive and accessible documentation suite for its end-to-end service.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature AliveCor QT Service Zio AT ECG Monitoring System
Name AliveCor QT Service Zio AT ECG Monitoring System
Company AliveCor iRhythm Technologies, Inc.
Description A cloud-based Software as a Medical Device (SaMD) that provides instant, accurate QT and QTc interval measurements from AliveCor 6-Lead ECGs, enabling healthcare professionals to assess cardiac safety and inform medication prescribing decisions. An FDA-cleared, wearable mobile cardiac telemetry (MCT) service offering continuous, AI-powered ECG monitoring for long-term arrhythmia detection and comprehensive reporting.
Key Features Cloud-based Software as a Medical Device (SaMD), Measures QT and QTc intervals (Bazett's and Fridericia's formulas), Analyzes ECGs from AliveCor 6-Lead ambulatory ECG devices (e.g., KardiaMobile 6L), Prescription (Rx) use only, for qualified healthcare professionals, Utilizes AI and deep neural networks for ECG analysis, Provides instant QT measurements (as InstantQT), Integrates with KardiaStation app and KardiaPro portal, API available for integration with EHR, SDK, CRM, EDC, and PSP platforms Wearable Zio AT patch for continuous ECG recording, Wireless gateway for real-time data transmission, FDA-cleared deep-learned AI algorithm (ZEUS System) for arrhythmia detection, Continuous, uninterrupted ECG recording for up to 14 days, Detection of symptomatic and asymptomatic cardiac events, Comprehensive end-of-wear reports for clinicians, ZioSuiteu00ae clinician portal and mobile app for patient management and report interpretation, MyZiou00ae patient mobile app for symptom logging and education
Categories Cardiology AI, Pharmacology & Dosing AI Cardiology AI, Wearables & Remote Monitoring (RPM)
Specialties Cardiology, Emergency Medicine, Internal Medicine Cardiology

Videos

Demos, reviews, and walkthroughs featuring AliveCor QT Service and Zio AT ECG Monitoring System.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

AliveCor QT Service is designed for instant, accurate QT and QTc interval measurements to assess cardiac safety and inform medication prescribing decisions. Zio AT ECG Monitoring System focuses on continuous, AI-powered ECG monitoring for long-term arrhythmia detection and comprehensive reporting of cardiac events.
AliveCor QT Service provides instant QT measurements from AliveCor 6-Lead ambulatory ECG devices. In contrast, the Zio AT ECG Monitoring System uses a wearable Zio AT patch for continuous, uninterrupted ECG recording for up to 14 days.
AliveCor QT Service delivers instant QT measurements, including QTc intervals calculated using Bazett's and Fridericia's formulas. Zio AT ECG Monitoring System provides comprehensive end-of-wear reports that detail the detection of symptomatic and asymptomatic cardiac events.
AliveCor QT Service is for Cardiology, Emergency Medicine, and Internal Medicine. The Zio AT ECG Monitoring System is primarily indicated for Cardiology.
AliveCor QT Service integrates with the KardiaStation app and KardiaPro portal, and offers an API for integration with EHR, SDK, CRM, EDC, and PSP platforms. Zio AT ECG Monitoring System uses the ZioSuite clinician portal and mobile app for patient management and report interpretation, alongside the MyZio patient mobile app for symptom logging.
AliveCor QT Service utilizes AI and deep neural networks for ECG analysis to provide instant QT measurements. The Zio AT ECG Monitoring System employs an FDA-cleared deep-learned AI algorithm (ZEUS System) specifically for arrhythmia detection.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.